EQ vs. ORKA
EQ (Equillium Inc) and ORKA (Oruka Therapeutics, Inc) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, EQ returned -16.50%/yr vs 36.46%/yr for ORKA. Their 0.17 correlation means their historical movements had little consistent relationship.
Performance
EQ vs. ORKA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EQ achieves a 41.94% return, which is significantly lower than ORKA's 218.41% return.
EQ
- 1D
- -5.17%
- 1M
- -24.40%
- 6M
- 54.93%
- YTD
- 41.94%
- 1Y
- 209.86%
- 3Y*
- 43.73%
- 5Y*
- -16.50%
- 10Y*
- —
- ALL TIME*
- -21.37%
ORKA
- 1D
- -1.38%
- 1M
- 13.26%
- 6M
- 181.95%
- YTD
- 218.41%
- 1Y
- 609.63%
- 3Y*
- 93.94%
- 5Y*
- 36.46%
- 10Y*
- -12.31%
- ALL TIME*
- -28.21%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $1.16M | $2.28M | $2.35M | |
| $77.59M | $103.90M | $107.56M |
EQ vs. ORKA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
EQ Equillium Inc | 41.94% | 107.16% | 3.49% | -31.79% | -71.88% | -29.53% | 58.28% | -58.58% | -43.14% |
ORKA Oruka Therapeutics, Inc | 218.41% | 56.32% | 76.73% | -28.27% | 10.23% | -46.38% | -29.77% | -4.88% | -40.45% |
Correlation
The correlation between EQ and ORKA is 0.22, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.22 |
Correlation (3Y) Balances recent behavior with more history. | 0.18 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.17 |
Correlation (All Time) Calculated using the full available price history since Oct 12, 2018 | 0.17 |
Fundamentals
EQ:
$78.15M
ORKA:
$3.61B
EQ:
-$0.26
ORKA:
-$2.27
EQ:
3.56
ORKA:
11.01
EQ:
$0.00
ORKA:
$0.00
EQ:
-$83.00K
ORKA:
-$71.00K
EQ:
-$19.95M
ORKA:
-$125.61M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EQ vs. ORKA — Risk / Return Rank
EQ
ORKA
EQ vs. ORKA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Equillium Inc (EQ) and Oruka Therapeutics, Inc (ORKA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| EQ | ORKA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -5.03 | ||
| Sortino ratioReturn per unit of downside risk | -1.65 | ||
| Omega ratioGain probability vs. loss probability | 1.47 | 1.68 | -0.21 |
| Calmar ratioReturn relative to maximum drawdown | 8.07 | 22.00 | -13.93 |
| Martin ratioReturn relative to average drawdown | 17.56 | 71.65 | -54.09 |
Loading charts...
Drawdowns
EQ vs. ORKA - Drawdown Comparison
The maximum EQ drawdown since its inception was -98.91%, roughly equal to the maximum ORKA drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for EQ and ORKA.
Loading charts...
Drawdown Indicators
| EQ | ORKA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.91% | -100.00% | +1.09% |
Max Drawdown (1Y)Largest decline over 1 year | -57.79% | -27.99% | -29.80% |
Max Drawdown (3Y)Largest decline over 3 years | -90.33% | -77.76% | -12.57% |
Max Drawdown (5Y)Largest decline over 5 years | -95.85% | -77.76% | -18.09% |
Max Drawdown (10Y)Largest decline over 10 years | — | -98.10% | — |
Current DrawdownCurrent decline from peak | -91.70% | -100.00% | +8.30% |
Average DrawdownAverage peak-to-trough decline | -85.03% | -93.90% | +8.87% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 26.51% | 8.58% | +17.93% |
Volatility
EQ vs. ORKA - Volatility Comparison
Equillium Inc (EQ) and Oruka Therapeutics, Inc (ORKA) have volatilities of 21.32% and 20.74%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EQ | ORKA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.32% | 20.74% | +0.58% |
Volatility (6M)Calculated over the trailing 6-month period | 66.39% | 53.50% | +12.89% |
Volatility (1Y)Calculated over the trailing 1-year period | 163.27% | 78.13% | +85.14% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 115.10% | 72.55% | +42.55% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 286.04% | 152.67% | +133.37% |
Dividends
EQ vs. ORKA - Dividend Comparison
Neither EQ nor ORKA has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
EQ Equillium Inc | 0.00% | 0.00% | 0.00% |
ORKA Oruka Therapeutics, Inc | 0.00% | 0.00% | 99.82% |
Financials
EQ vs. ORKA - Financials Comparison
This section allows you to compare key financial metrics between Equillium Inc and Oruka Therapeutics, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
EQ and ORKA have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EQ has higher volatility (21.32%) compared to ORKA (20.74%). In terms of maximum drawdown, EQ dropped -98.91% vs ORKA's -100.00%.
ORKA currently has the higher Sharpe Ratio (7.88 vs 2.86), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EQ and ORKA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer